|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2007-2-1
|
|
pubmed:abstractText |
Trials have demonstrated benefits of long-chain omega-3 essential fatty acid (n-3 EFA) supplementation in a variety of psychiatric disorders.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-1250
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
190
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
118-22
|
|
pubmed:dateRevised |
2007-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:17267927-Adult,
pubmed-meshheading:17267927-Dietary Supplements,
pubmed-meshheading:17267927-Docosahexaenoic Acids,
pubmed-meshheading:17267927-Double-Blind Method,
pubmed-meshheading:17267927-Eicosapentaenoic Acid,
pubmed-meshheading:17267927-Female,
pubmed-meshheading:17267927-Humans,
pubmed-meshheading:17267927-Male,
pubmed-meshheading:17267927-Psychiatric Status Rating Scales,
pubmed-meshheading:17267927-Recurrence,
pubmed-meshheading:17267927-Risk Factors,
pubmed-meshheading:17267927-Self-Injurious Behavior,
pubmed-meshheading:17267927-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial.
|
|
pubmed:affiliation |
Department of Psychiatry, Beaumont Hospital and The Royal College of Surgeons in Ireland, Ireland.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
